🇺🇸 FDA
Patent

US 8153668

Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate

granted A61PA61P1/00A61P17/00

Quick answer

US patent 8153668 (Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P1/00, A61P17/00, A61P17/06, A61P19/02